All In Biotech

Free tool

FAERS Monitor: Gimoti

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209388 or its brand name (Gimoti, Metoclopramide Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

9,040

Serious

7,706

85% of reports

Hospitalization

3,403

Death reported

1,097

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • tardive dyskinesia2,414
  • extrapyramidal disorder1,094
  • nausea829
  • incorrect drug administration duration691
  • off label use605
  • diarrhoea507
  • vomiting486
  • drug ineffective419
  • nervous system disorder404
  • pyrexia379
  • headache371
  • tremor365
  • dyspnoea351
  • fatigue348
  • dystonia338

Reports by year received

View as table
YearReports
200452
200566
200646
200756
200857
2009101
2010243
20112,040
2012331
2013353
2014358
201577
2016116
2017169
2018207
2019297
2020300
2021586
2022905
2023840
2024782
2025647
2026407

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,119 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
tardive dyskinesiaSignal2,414217.6209.9476,424
extrapyramidal disorderSignal1,094107.2101.2110,032
incorrect drug administration durationSignal69158.654.538,137
dystoniaSignal33841.237.113,015
nervous system disorderSignal40430.527.711,370
tremorSignal3655.14.61,215
pyrexiaSignal3792.62.3361
nauseaSignal8292.42.3729
vomitingSignal4862.42.2407
diarrhoea5071.81.7195
off label use6051.61.5144
dyspnoea3511.41.349
headache3711.41.239
fatigue3481.00.91
drug ineffective4190.70.741

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.